Zoetis Sets New 1-Year High at $35.03 (ZTS)
Zoetis (NYSE:ZTS)’s share price reached a new 52-week high on Monday , Analyst Ratings Network.com reports. The stock traded as high as $35.03 and last traded at $34.90, with a volume of 1,113,776 shares trading hands. The stock had previously closed at $34.89.
Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Zoetis from $38.00 to $37.00 in a research note on Monday, August 11th. They now have a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Zoetis in a research note on Wednesday, August 6th. They now have a $34.00 price target on the stock. Finally, analysts at BMO Capital Markets cut their price target on shares of Zoetis from $37.00 to $36.00 in a research note on Wednesday, August 6th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $29.80.
The stock has a 50-day moving average of $32.95 and a 200-day moving average of $31.09. The company has a market cap of $17.499 billion and a P/E ratio of 33.23.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 2nd. Investors of record on Wednesday, August 20th will be paid a dividend of $0.072 per share. This represents a $0.29 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Monday, August 18th.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
Receive News & Ratings for Zoetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.